May 8 |
Stoke Therapeutics Inc (STOK) Reports Q1 2024 Financial Results: A Closer Look at Challenges ...
|
May 7 |
Stoke Therapeutics First Quarter 2024 Earnings: Beats Expectations
|
May 6 |
Analyst Expectations For Stoke Therapeutics's Future
|
May 6 |
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
|
May 6 |
Stoke Therapeutics GAAP EPS of -$0.57, revenue of $4.2M
|
May 6 |
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
|
Apr 29 |
Stoke Therapeutics appoints CFO
|
Apr 29 |
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
|
Apr 25 |
Earnings Preview: Stoke Therapeutics, Inc. (STOK) Q1 Earnings Expected to Decline
|
Apr 17 |
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
|